Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AbbVie And Allergan: Five Big Review Questions To Worry About

Jul 14 2019

• By Bridget Silverman

Los Angeles, California, USA - June 30 2019 : Homepage of Abbvie .Official website of company . - Image

Related Content

Keeping Track: Industry Channels Inner Gottlieb As Commissioner Departs US FDA

Apr 06 2019

Vanda Puts Dog Studies In Spotlight In Suit Challenging FDA Clinical Hold

Feb 11 2019

AbbVie Spotlights Its Early-Stage R&D Pipeline

May 01 2019

AbbVie’s Business Development, Cancer Plans Not Put Off By Stemcentrx Disappointments

Jan 10 2019

Biohaven Pays $105m For Turbo Boost In Migraine Drug Review Race

Mar 20 2019

Gilead To File Filgotinib For RA in 2019, Earlier Than Forecast

Jul 02 2019

Allergan Relying On 'Six Stars' And Other R&D Programs To Blunt Restasis Blow

Jan 19 2018

Allergan's Ubrogepant Succeeds In Second Acute Migraine Phase III Study

Apr 28 2018

AbbVie's Rova-T Disappoints As Second-Line SCLC Trial Halted

Dec 06 2018

Allergan Touts Ubrogepant Phase III Success, But Liver Tox Concerns Overhang

Feb 06 2018

AbbVie Ups The Ante For Upadacitinib At EULAR

Jun 17 2019

AbbVie Pounces On Chance To Buy Revenues In $63bn Mega-Deal For Allergan

Jun 25 2019

Cautious Restart To Venetoclax’s CANOVA Trial In Multiple Myeloma

Jun 25 2019

Related Companies

AbbVie Inc.

Allergan plc

Novartis AG

Amgen, Inc.

Boehringer Ingelheim GmbH

Pfizer Inc.

Samsung Bioepis Co., Ltd.

Biohaven Pharmaceutical Holding Company Ltd.

GW Pharmaceuticals plc

Eli Lilly and Company

Catalent, Inc

Merck & Co., Inc.

Roche Holding AG

Bristol Myers Squibb Company

Gilead Sciences, Inc.

Rhythm Pharmaceuticals, Inc.

Evoke Pharma, Inc.

Johnson & Johnson

Vanda Pharmaceuticals, Inc.

Additional Topics

United States Drug Review M & A Regulation BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.